NH Zuma, J Aucamp, DND David - European Journal of Pharmaceutical …, 2019 - Elsevier
nitrofurans (NFs) have been in clinical use for over 60 years. These affordable drugs are used for the treatment of a broad spectrum of diseases ranging from urinary tract infections …
The development of drug-resistant tuberculosis (TB) is a major global threat worldwide. Based on the World Health Organization reports, it is estimated that more than 500000 new …
Current guidelines regarding management of spinal TB are mostly extrapolated from trials on pulmonary disease. Since the British Medical Research Council (BMRC) trials in the …
Bedaquiline (TMC-207) is a recently approved drug for the treatment of multidrug-resistant tuberculosis (MDR-TB). Moreover, there is a present and growing concern for natural …
P Kotwal, A Magotra, A Dogra, S Sharma… - … of Chromatography B, 2019 - Elsevier
A continuous effort has been given to find out a new drug that is effective against tuberculosis (TB) from both susceptible and resistant strains of Mycobacterium tuberculosis …
Bedaquiline (BDQ), a diarylquinoline demonstrating significant bactericidal and sterilizing activity, has been approved by the US Food and Drug Administration for the treatment of …
A Kunkel, J Furin, T Cohen - The Lancet Infectious Diseases, 2017 - thelancet.com
Global rollout of the new antituberculosis drug bedaquiline has been slow, in part reflecting concerns about spread of bedaquiline resistance. Acquired resistance to bedaquiline is …
AZ Abbas, SJ Mohammed - Iraqi Postgraduate Medical Journal, 2021 - iasj.net
Assessment of Knowledge and Attitudes of Medical Students on Tuberculosis Page 1 ATTITUDES OF MEDICAL STUDENTS ON TUBERCULOSIS THE IRAQI POSTGRADUATE …